OTUD6B and colorectal carcinoma: Further studies found that OTUD6B-AS1 can bind HuR to stabilize TRIM16, enhancing GPX4-mediated ferroptosis and improving CRC radiotherapy sensitivity, whereas low expression of OTUD6B-AS1 resulted in CRC radiotherapy resistance [167].